Hepatic macrophages: Key players in the development and progression of liver fibrosis
D Cheng, J Chai, H Wang, L Fu, S Peng… - Liver …, 2021 - Wiley Online Library
Hepatic fibrosis is a common pathological process involving persistent liver injury with
various etiologies and subsequent inflammatory responses that occur in chronic liver …
various etiologies and subsequent inflammatory responses that occur in chronic liver …
Therapeutic targeting of hepatic macrophages for the treatment of liver diseases
D van der Heide, R Weiskirchen, R Bansal - Frontiers in immunology, 2019 - frontiersin.org
Hepatic macrophages play a central role in maintaining homeostasis in the liver, as well as
in the initiation and progression of liver diseases. Hepatic macrophages are mainly derived …
in the initiation and progression of liver diseases. Hepatic macrophages are mainly derived …
The molecular mechanisms of liver fibrosis and its potential therapy in application
D Zhang, Y Zhang, B Sun - International Journal of Molecular Sciences, 2022 - mdpi.com
Liver fibrosis results from repeated and persistent liver damage. It can start with hepatocyte
injury and advance to inflammation, which recruits and activates additional liver immune …
injury and advance to inflammation, which recruits and activates additional liver immune …
Targeting of hepatic macrophages by therapeutic nanoparticles
CI Colino, JM Lanao, C Gutierrez-Millan - Frontiers in immunology, 2020 - frontiersin.org
Hepatic macrophage populations include different types of cells with plastic properties that
can differentiate into diverse phenotypes to modulate their properties in response to different …
can differentiate into diverse phenotypes to modulate their properties in response to different …
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Although several nanomedicines got clinical approval over the past two decades, the clinical
translation rate is relatively small so far. There are many post-surveillance withdrawals of …
translation rate is relatively small so far. There are many post-surveillance withdrawals of …
Monocyte-endothelial cell interactions in vascular and tissue remodeling
M Medrano-Bosch, B Simón-Codina… - Frontiers in …, 2023 - frontiersin.org
Monocytes are circulating leukocytes of innate immunity derived from the bone marrow that
interact with endothelial cells under physiological or pathophysiological conditions to …
interact with endothelial cells under physiological or pathophysiological conditions to …
Multifunctional nanoparticles boost cancer immunotherapy based on modulating the immunosuppressive tumor microenvironment
J Li, M Zhao, M Sun, S Wu, H Zhang… - ACS Applied Materials …, 2020 - ACS Publications
Cancer immunotherapy has been a favorable strategy for facilitating antitumor immunity.
However, immune tolerance and an ultimate immunosuppressive tumor microenvironment …
However, immune tolerance and an ultimate immunosuppressive tumor microenvironment …
Polymeric nanomedicines for the treatment of hepatic diseases
The liver is an important organ in the human body and performs many functions, such as
digestion, detoxification, metabolism, immune responses, and vitamin and mineral storage …
digestion, detoxification, metabolism, immune responses, and vitamin and mineral storage …
BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling
C Kerneur, E Foucher, JG Casas, M Colazet, KS Le… - Cell Reports, 2024 - cell.com
Summary Tumor-associated macrophages (TAMs), often adopting an immunosuppressive
M2-like phenotype, correlate with unfavorable cancer outcomes. Our investigation unveiled …
M2-like phenotype, correlate with unfavorable cancer outcomes. Our investigation unveiled …
[HTML][HTML] Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and …
DW Kurniawan, R Booijink, L Pater, I Wols… - Journal of controlled …, 2020 - Elsevier
Liver diseases are the growing health problem with no clinically approved therapy available.
Activated hepatic stellate cells (HSCs) are the key driver cells responsible for extracellular …
Activated hepatic stellate cells (HSCs) are the key driver cells responsible for extracellular …